The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, LifeMD Inc (NASDAQ: LFMD) closed at $3.97 up 3.12% from its previous closing price of $3.85. In other words, the price has increased by $3.12 from its previous closing price. On the day, 1.11 million shares were traded. LFMD stock price reached its highest trading level at $4.055 during the session, while it also had its lowest trading level at $3.91.
Ratios:
For a deeper understanding of LifeMD Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.08. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.73. In the meantime, Its Debt-to-Equity ratio is 4.98 whereas as Long-Term Debt/Eq ratio is at 4.47.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 24 ’25 when FRIEDEMAN JESSICA bought 20,000 shares for $4.04 per share.
Alvarez Nicholas P sold 75,000 shares of LFMD for $443,760 on Sep 10 ’25. The Chief Acquisition Officer now owns 605,000 shares after completing the transaction at $5.92 per share. On Sep 10 ’25, another insider, Alvarez Nicholas P, who serves as the Officer of the company, bought 75,000 shares for $6.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 191099456 and an Enterprise Value of 175892800. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.76 while its Price-to-Book (P/B) ratio in mrq is 140.73. Its current Enterprise Value per Revenue stands at 0.703 whereas that against EBITDA is -129.113.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.46, which has changed by -0.39274448 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.43. The 50-Day Moving Average of the stock is -32.10%, while the 200-Day Moving Average is calculated to be -48.48%.
Shares Statistics:
For the past three months, LFMD has traded an average of 1.22M shares per day and 2283910 over the past ten days. A total of 46.58M shares are outstanding, with a floating share count of 39.28M. Insiders hold about 18.40% of the company’s shares, while institutions hold 42.89% stake in the company. Shares short for LFMD as of 1761868800 were 4181527 with a Short Ratio of 3.43, compared to 1759190400 on 4721990. Therefore, it implies a Short% of Shares Outstanding of 4181527 and a Short% of Float of 10.5900005.
Earnings Estimates
The market rating of LifeMD Inc (LFMD) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.42 and -$0.23 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.14, with 2.0 analysts recommending between $0.55 and -$0.26.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $48.57M this quarter.It ranges from a high estimate of $58M to a low estimate of $45M. As of. The current estimate, LifeMD Inc’s year-ago sales were $64.25MFor the next quarter, 8 analysts are estimating revenue of $50.07M. There is a high estimate of $58.75M for the next quarter, whereas the lowest estimate is $47.1M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $246.1M, while the lowest revenue estimate was $233.09M, resulting in an average revenue estimate of $236.72M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $224.04M in the next fiscal year. The high estimate is $249.2M and the low estimate is $197M.
